Emmanuel Igho, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1045 Thomas St, Hillside, NJ 07205 Phone: 718-671-2100 |
Youmane Paul, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 75 Wolf Pl, Hillside, NJ 07205 Phone: 862-452-1063 |
Mrs. Berty Ati, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 571 Chapman St, Hillside, NJ 07205 Phone: 561-846-1369 |
Carolyn Dick, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 320 Hillside Ave, Hillside, NJ 07205 Phone: 800-950-6066 |
Shanice Bland, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 358 Long Ave, Hillside, NJ 07205 Phone: 908-994-9383 |
Ms. Dorothy M Cajuste-leger, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 574 Purce St, Hillside, NJ 07205 Phone: 908-688-1168 |
Martine Garcon, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 229 Conklin Ave, Hillside, NJ 07205 Phone: 973-868-4901 |
News Archive
Obstructive sleep apnea (OSA) may increase the risk of developing atrial fibrillation (AF), according to new research presented at the ATS 2017 International Conference.
BioMedix Vascular Solutions, Inc. announced today that John Romans, CEO and Meg Heim, RN, Vice President of Marketing have been invited to participate as members of the P.A.D. Task Force Committee on behalf of the Governor of California, Arnold Schwarzenegger, The California Podiatric Medical Association and the California Department of Chronic Disease and Injury Prevention (CDPH). The committee will meet today, February 4th, 2010 in the California State Capitol, Governors conference room.
Following a shift in its business model from developing proprietary pain therapy products to pure contract research, Algos Therapeutics has changed its name to Algos Preclinical Services. The company's new tagline, "Expertise in pain. Legendary service. Definitive results. For better quality of life." reinforces its repositioning as the go-to-CRO (Contract Research Organization) for drug discovery and product development.
A team of scientists, led by researchers at University of California, San Diego Moores Cancer Center and The University of Texas MD Anderson Cancer Center, report that a genetic biomarker called loss of heterozygosity or LOH is able to predict which patients with premalignant mouth lesions are at highest risk of developing oral cancer.
The split-bolus (cross sectional imaging) MDCT urography technique reduces both radiation dose and number of images produced, according to a recent study conducted by radiologists from Stanford University School of Medicine in Stanford, CA and VA Palo Alto Health Care System in Palo Alto, CA.
› Verified 6 days ago